Literature DB >> 8175725

Identification of a novel growth factor-responsive gene in vascular smooth muscle cells.

S D Wax1, C L Rosenfield, M B Taubman.   

Abstract

We have employed differential screening of a rat aortic smooth muscle cell cDNA library to isolate a cDNA clone, SM-20, whose nucleotide and deduced amino acid sequences are distinct from those reported previously. SM-20 encodes an mRNA of approximately 2.5-3.0 kilobase pairs which is present at low levels in quiescent vascular smooth muscle cells. SM-20 levels increase within 1 h of treatment with growth agonists (serum, platelet-derived growth factor, angiotensin II), isoproterenol, and forskolin. Cycloheximide induces high levels of SM-20 mRNA and superinduces it in the presence of serum, suggesting that the increase in SM-20 mRNA levels is not dependent on protein synthesis and is part of the primary response to growth agonists. SM-20 is expressed at high levels in tissues and cells derived from muscle (smooth, skeletal, and cardiac) and nerve (brain, PC12 cells) and is not expressed in 3T3 fibroblasts or rat 6 fibroblasts. SM-20 encodes a new member of the immediate early gene family and is unusual in that it is expressed in vascular smooth muscle, but not in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175725

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Novel antimicrobial targets from combined pathogen and host genetics.

Authors:  C D Johnson; L X Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation.

Authors:  M C Moschella; K Menzies; L Tsao; M A Lieb; J D Kohtz; D S Kohtz; M B Taubman
Journal:  Gene Expr       Date:  1999

Review 3.  Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model.

Authors:  Zachary Spicer; David E Millhorn
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 4.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

5.  Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa.

Authors:  C Darby; C L Cosma; J H Thomas; C Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 6.  Hypoxia inducible factor-1: its potential role in cerebral ischemia.

Authors:  Neetu Singh; Gaurav Sharma; Vikas Mishra
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

7.  Identification of mRNAs differentially expressed in quiescence or in late G1 phase of the cell cycle in human breast cancer cells by using the differential display method.

Authors:  R S Alpan; S Sparvero; A B Pardee
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

8.  Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.

Authors:  Mircea Ivan; Thomas Haberberger; David C Gervasi; Kristen S Michelson; Volkmar Günzler; Keiichi Kondo; Haifeng Yang; Irina Sorokina; Ronald C Conaway; Joan W Conaway; William G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-26       Impact factor: 11.205

9.  Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels.

Authors:  A S Weintraub; C M Giachelli; R S Krauss; M Almeida; M B Taubman
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

10.  EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.

Authors:  Jian Fu; Mark B Taubman
Journal:  Mol Cell Biol       Date:  2013-06-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.